Pennys stock

KaloBios Pharmaceuticals Inc (NASDAQ: KBIO) is a monoclonal antibody therapeutics company that traded as a penny stock as recently as this Monday. The company now trades above the $15.00 mark on Wednesday's after-hours session after an SEC disclosure from noted biotech investor Martin Shkreli...